Skip to content
10-Q

Quarterly Report

BioCrude Technologies USA, Inc.

0001731122-25-000732

← back to feed
Filed
May 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 14, 2025 50.85M sh
Short Term Debt Q1 2025 · Mar 31, 2025 $131.43K
Short Term Debt Q1 2025 · Dec 31, 2024 $130.64K
Stockholders Equity Q1 2025 · Mar 31, 2025 −$358.97K
Stockholders Equity Q1 2025 · Dec 31, 2024 −$299.03K
Current Liabilities Q1 2025 · Mar 31, 2025 $380.5K
Current Liabilities Q1 2025 · Dec 31, 2024 $322.13K
Total Liabilities Q1 2025 · Mar 31, 2025 $380.5K
Total Liabilities Q1 2025 · Dec 31, 2024 $322.13K
Current Assets Q1 2025 · Mar 31, 2025 $5.2K
Current Assets Q1 2025 · Dec 31, 2024 $5.2K
Total Assets Q1 2025 · Mar 31, 2025 $17.88K
Total Assets Q1 2025 · Dec 31, 2024 $19.09K
Shares Diluted Q1 2025 · Mar 31, 2024 50.8M sh
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$79.39K
Eps Diluted Q1 2025 · Mar 31, 2024 $0.00
Eps Basic Q1 2025 · Mar 31, 2024 $0.00
Sga Expense Q1 2025 · Mar 31, 2024 $122.6K
Net Income Q1 2025 · Mar 31, 2024 −$123.54K
Operating Income Q1 2025 · Mar 31, 2024 −$122.6K